CompoAtlas

Insomnitol

Natural health product licensed in Canada

Licence holder
Designs for Health
NPN or DIN-HM
80051334
Status
Active licence
Licence date
2 June 2014
Revision date
28 January 2026
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Camomile

Source : Matricaria chamomilla, fleur

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1,000 mg

100 mgNot calculated
Acide gamma-aminobutyrique

Source : Acide 4-aminobutanoïque

50 mgNot calculated
Mélisse

Source : Melissa officinalis - Herb top

Extract : Matériel brut sec

Extraction ratio : 4-6:1

Dry plant equivalent : 400-600 mg

Potency : 3 % Rosemarinic Acid

100 mgNot calculated
L-5-HTP

Source : 5-HTP

50 mgNot calculated
L-5-HTP

Source : Griffonia simplicifolia, graine

50 mgNot calculated
L-théanine

Source : L-Théanine

50 mgNot calculated
N-acétyl-5-méthoxytryptamine

Source : Mélatonine

1.5 mgNot calculated
Passiflore

Source : Passiflora incarnata - Herb top

Extract : Matériel brut sec

Extraction ratio : 4-6:1

Dry plant equivalent : 400-600 mg

Potency : 3.5 % Bioflavonoids

100 mgNot calculated
Valériane

Source : Valeriana officinalis

Extraction ratio : 3-6:1

Dry plant equivalent : 600-1200 mg

Potency : 0.8 % Valerenic Acid

200 mgNot calculated
Vitamine B6

Source : Spinacia oleracea - feuille

5 mg10,000 µg

Non-medicinal ingredients

Acide stéarique, Dioxyde de silicium, Stéarate de magnésium, Hypromellose

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Used as a sleep aid. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Helps re-set the body's sleep-wake cycle (Aspect of the circadian rhythm).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80051334

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line